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Synopsis
Whereas NASH is associated with poor long-term outcome, widespread screening is not currently feasible given that a deﬁnitive
diagnosis of NASH can only be made through liver biopsy. In this study, a virtual liver biopsy was developed with machine learning from
mixed multiparametric MRI radiomics and biological data.
Introduction
In the past decade, an epidemic increase in non-alcoholic fatty liver disease (NAFLD) prevalence has been observed in Western countries and
NAFLD is among the most common causes of chronic liver disease with a prevalence ranging between 17 and 46% (1). NAFLD include simple
steatosis and nonalcoholic steato-hepatitis (NASH). Whereas simple steatosis has good prognosis, NASH is associated with poor long-term outcome
(2) and is characterized by steatosis, hepatocyte ballooning, inﬂammation, with or without ﬁbrosis at histology. About 20% of NASH patients
develop cirrhosis or hepatocellular carcinoma, so that NASH has become the fastest growing cause of liver-related morbidity/mortality worldwide
(3). Widespread screening is not currently feasible given that a deﬁnitive diagnosis of NASH can only be made through identiﬁcation of the
characteristic histopathologic pattern on liver biopsy (4). Therefore, there is a pressing unmet medical need for reliable and accurate non-invasive
tools to evaluate liver steatosis, ﬁbrosis and inﬂammation simultaneously. The aim of this study was to develop a virtual liver biopsy based on
multiparametric MRI (mpMRI) radiomics and biological data.
Methods
70 patients with chronic liver diseases, histology (ISHAK classiﬁcation), blood serum markers and 3.0T mpMRI data available were retrospectively
enrolled from the HEPATOMAP database. Gd-BOPTA-enhanced (t = 20 min) fat-suppressed T1w images were used as a radiomic ﬁngerprint. PDFF-
map was computed from chemical-shift-encoded acquisition according to (5). ASAT, ALAT and Gamma GT-values were recorded. From BOPTA-
enhanced radiomic ﬁngerprint, the liver were manually segmented to extract the radiome including 87 features describing shape, size, distribution
and texture in images and frequency domain (Fig.1). Overall, 91 features were integrated. The learning base dimension was reduced using a
backward selection by thresholding on t-test p-value (t < 0.05). Two models were established to predict advanced ﬁbrosis (F > 2, n = 35) and
inﬂammation (A > 1, n = 46). To predict inﬂammation, a k-nearest neighbor algorithm with a cosine node function and 10 neighbors was used as a
classiﬁer. To predict ﬁbrosis, a support vector machine with a linear kernel was used as a classiﬁer. Steatosis grades were predicted without
classiﬁer and directly from the mean PDFF-value. Internal validation was performed with a holdout cross-validation method (75% of data used for
training and 25% for test).
Results
Diagnosis performances to predict steatosis grades, advanced ﬁbrosis and inﬂammation are summarized in Fig.2.
Discussion
This work shows the feasibility to predict key liver histological characteristics (steatosis, ﬁbrosis and inﬂammation) with mixed radiomics and
biological data in patients with chronic liver diseases. Limitations of the study are the absence of external validation and the heterogeneity of
etiologies in the database. Shared multicenter data are mandatory to extend this proof of concept to NASH only, to perform a thinner classiﬁcation,
and to obtain an external validation.
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Fig.1: Radiome extraction pipeline. Size and shape features were extracted from the binary mask. Intensity distribution features were extracted
from the histogram built with 256 bins. Images gray levels were discretized in a smaller number of gray levels with an equal probability algorithm.
Images were discretized in 8, 16, 24, 32, 40, 48 and 64 grey levels. For each discretization level, four matrixes were built: GLCM (Gray-level co-
occurrence), GLRLM (Gray-level run length), GLSZM (Gray-level size zone) and NGTDM (Neighborhood gray tone diﬀerence) from which
characteristics were extracted, then averaged. Frequency domain-based texture features were extracted using a Gabor ﬁltering.
Fig.2: Diagnosis performances to predict key liver histological characteristics (PPV and NPV are the negative predictive value and the positive
predictive value respectively)
